Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jürgen Boer"'
Autor:
Dorothea Piecha, Frank Richter, Bert Nolte, Darrell Nix, Gallagher Brian, Arthur G. Taveras, Gabriel Becher, Matthias Hochgürtel, Michael Essers, Xinyuan Wu, Tim Feuerstein, Ralf Biesinger, Alison M. Bendele, Hongbo Deng, Rory Dodd, Christian Gege, Lixia Jin, Andreas Timmermann, Brian Korniski, Harald Bluhm, Michael Hofmann, Bing Xia, Juergen Weik, Andrew Kiely, Matthias F. Schneider, Jürgen Boer, Heiko Kroth, Andreas Jaworski, Timothy Powers, Vijaykumar M. Baragi, Christoph Steeneck, Irving Sucholeiki, Joshua Van Veldhuizen
Publikováno v:
Arthritis & Rheumatism. 60:2008-2018
Objective Matrix metalloproteinases (MMPs) have long been considered excellent targets for osteoarthritis (OA) treatment. However, clinical utility of broad-spectrum MMP inhibitors developed for this purpose has been restricted by dose-limiting muscu
Publikováno v:
Angewandte Chemie International Edition. 44:927-932
Publikováno v:
Journal of Medicinal Chemistry. 46:5752-5762
As part of our ongoing research in the development of alpha4beta7 integrin antagonists, we are interested in peptidomimetics based on a rigid scaffold to allow the display of essential side chains in a suitable binding conformation while eliminating
Publikováno v:
Angewandte Chemie. 113:3988-3991
A cyclic peptide role model was used for the design and synthesis of a new class of biologically active and α4 -selective integrin antagonists (e.g. 1) based on β-D-mannose. These carbohydrate-based peptidomimetics were synthesized to include the f
Autor:
Brian Korniski, Taveras Arthur G, Jürgen Boer, Christian Gege, Gallagher Brian, Harald Bluhm, Vijaykumar M. Baragi, Christoph Steeneck, Bagna Bao, Timothy Powers
Publikováno v:
Journal of medicinal chemistry. 55(2)
Osteoarthritis (OA) is a nonsystemic disease for which no oral or parenteral disease-modifying osteoarthritic drug (DMOAD) is currently available. Matrix metalloproteinase 13 (MMP-13) has attracted attention as a target with disease-modifying potenti
Autor:
Dirk, Gottschling, Jürgen, Boer, Luciana, Marinelli, Georg, Voll, Melina, Haupt, Anja, Schuster, Bernhard, Holzmann, Horst, Kessler
Publikováno v:
Chembiochem : a European journal of chemical biology. 3(6)
Publikováno v:
Angewandte Chemie (International ed. in English). 41(16)
Publikováno v:
Bioorganicmedicinal chemistry letters. 11(23)
A qualitative cellular solid-phase binding assay for screening α4β7 integrin antagonists attached via photolinker to TentaGel® Macrobeads has been developed. An activation of the integrins with Mn 2+ was necessary to achieve binding to the bead bo
Publikováno v:
Angewandte Chemie (International ed. in English). 40(20)
Autor:
Bernhard Holzmann, Jürgen Boer, Anja Schuster, Monika Semmrich, Dirk Gottschling, Horst Kessler
Publikováno v:
Journal of medicinal chemistry. 44(16)
Interactions of the integrins alpha(4)beta(7) with its cognate ligand mucosal addressin cell adhesion molecule-1 (MAdCAM-1) play a crucial role in the development of mucosa-associated lymphoid organs, in the generation of mucosal immune responses, an